Pierluigi Viale to HIV Integrase Inhibitors
This is a "connection" page, showing publications Pierluigi Viale has written about HIV Integrase Inhibitors.
Connection Strength
0.149
-
Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study). Infect Dis (Lond). 2017 Oct; 49(10):737-747.
Score: 0.149